Osiris Therapeutics, Inc. has a number of openings which offer an exciting opportunity to participate in the development of novel therapeutic products for the regeneration of tissue using proprietary mesenchymal stem cell (MSC) technology.
A leader in development of stem cell therapy for regenerative medicine:
Since 1992, Osiris has been developing its portfolio of stem cell based drug candidates and production capabilities.
